Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Italy

Marie Skłodowska-Curie Action · Running

HEAL-4WARD HEAL-4WARD - doctoral network for Wound infection Advanced care and Rapid Diagnosis

Coordinator
Universita Degli Studi Di Roma La Sapienza, Italy
Runs
1 March 2026 to 28 February 2030
Status
Running
EU funding
€3.3m
Total cost
—
Partners
19 organisations in 9 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101226731

What the project is doing

In the project's own words, from its summary on CORDIS.

The HEAL-4WARD doctoral network aims to train 11 Doctoral Candidates (DCs) across Europe to tackle the critical challenge of wound infections. By integrating cutting-edge nanomaterials, non-invasive label-free detection technologies, innovative additive manufacturing (3D-printing) and Artificial Intelligence models, we will prototype smart wound patches for personalized infection care and diagnosis. Our focus is on developing on-demand antimicrobial strategies that minimize antimicrobial resistance risks, coupled with advanced label-free diagnostics and imaging capabilities.

This initiative brings together an academic and industrial multidisciplinary consortium of experts in (nano)material science, chemistry, additive manufacturing, biomedical engineering, molecular biology, microbiology, and clinical practice. Our goal is to translate and combine innovative technologies from the laboratory to prototype to clinical settings, enhancing patient outcomes and reducing the burden of infections on healthcare systems.

DCs will receive comprehensive training across these different and cross-section fields, training them with skills and knowledge to tackle antimicrobial resistance in wound healing and at the same time to create groundbreaking solutions that position Europe at the forefront of personalized medical devices. Our focus on skin and soft tissue infections, including surgical site infections, acute burns, and chronic wounds such as diabetic foot ulcers, venous leg ulcers, and pressure sores, addresses the high prevalence of these conditions in hospitals and long-term care facilities.

This emphasizes the urgent need for personalized treatment strategies to improve patient care and healthcare efficiency.

Topics

Who is involved

OrganisationCityCountryRole
Universita Degli Studi Di Roma La SapienzaRomaItalyCoordinator
Accelopment Schweiz AGZurichSwitzerlandAssociatedpartner
Elliniko Instituto Meletis Tis SipsisAthensGreeceAssociatedpartner
Ethniko Kai Kapodistriako Panepistimio AthinonAthinaGreeceParticipant
Asociacion Centro De Investigacion Cooperativa En Biomateriales- Cic BiomaguneSan SebastianSpainParticipant
Universidad De VigoVigo PontevedraSpainParticipant
Universidad Del Pais Vasco/ Euskal Herriko UnibertsitateaLeioaSpainAssociatedpartner
Centre National De La Recherche Scientifique CNRSParisFranceParticipant
European Technology Platform on Nanomedecine EtpnParisFranceAssociatedpartner
Universite De ToulouseToulouseFranceAssociatedpartner
Universite Paris Xii Val De MarneCreteilFranceAssociatedpartner
Royal College of Surgeons in IrelandDublin 2IrelandParticipant
Fondazione Santa LuciaRomaItalyParticipant
Spiga Nord SpACarascoItalyAssociatedpartner
Ourobionics B.V.ArnhemNetherlandsAssociatedpartner
Rijksuniversiteit GroningenGroningenNetherlandsParticipant
Karolinska InstitutetStockholmSwedenAssociatedpartner
Global Sepsis AllianceTilehurstUnited KingdomAssociatedpartner
The University of NottinghamNottinghamUnited KingdomParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI